Multiple sclerosis: European Commission has approved Lemtrada
Genzyme has announced that the European Commission ( EC ) has granted marketing authorization for Lemtrada ( Alemtuzumab ).
Lemtrada is indicated for the treatment of adult patients with relapsing re ...
read article